Nottingham, United Kingdom

Julie Carolyn Gill

This inventor holds 2 USPTO granted patents. Top assignee: Knoll Aktiengesellschaft. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie Carolyn Gill. Retrieved from https://idiyas.com/inventor/julie-carolyn-gill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Julie Carolyn Gill: Innovator in CNS Disorder Treatments

Introduction

Julie Carolyn Gill is a prominent inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) disorders. With a total of 2 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Her latest patents include innovative compounds such as heteroarylcarboxamide derivatives for treating CNS disorders and naphthyridine derivatives. These inventions represent a step forward in developing effective treatments for complex neurological conditions.

Career Highlights

Julie is currently employed at Knoll Aktiengesellschaft, where she continues to push the boundaries of pharmaceutical research. Her dedication to innovation has positioned her as a key player in her field.

Collaborations

Throughout her career, Julie has collaborated with notable colleagues, including Alan Martin Birch and Paul Anthony Bradley. These partnerships have enhanced her research and contributed to her success as an inventor.

Conclusion

Julie Carolyn Gill's work in developing new treatments for CNS disorders showcases her commitment to innovation and her impact on the pharmaceutical industry. Her contributions are paving the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…